FIP in Cats: The Revolution in Treatment and Welfare
Feline infectious peritonitis (FIP), once universally fatal, can now be treated successfully with antiviral drugs, transforming the welfare outlook for affected cats.
Key Facts
- FIP is caused by a mutated form of feline coronavirus that causes systemic vasculitis
- Previously 100% fatal, affecting young cats most commonly
- Antiviral drugs (GS-441524 and related compounds) achieve remission in over 85% of cases
- Treatment requires 84 days of daily antiviral injections or oral medication
- Access to licensed treatments is improving globally, though cost remains a barrier
Welfare Considerations
FIP represents one of veterinary medicine's most dramatic welfare transformations. A disease that was uniformly fatal for generations is now treatable, offering affected cats the prospect of full recovery and normal life expectancy. The welfare burden of treatment — daily injections for 12 weeks — must be weighed against the life-saving benefit. Monitoring during treatment uses clinical signs, bodyweight, and blood markers to confirm response. Relapse requiring retreatment occurs in a minority of cases. The remaining welfare challenge is ensuring that treatment is accessible to all FIP-affected cats regardless of owner resources, which requires policy and financial support mechanisms.
What You Can Do
- Seek immediate veterinary assessment if FIP is suspected — early treatment improves outcomes
- Pursue antiviral treatment — FIP is no longer a death sentence
- Source medication through your vet or legitimate licensed suppliers
- Monitor treatment response closely using the parameters your vet provides
- Support organizations working to improve FIP treatment access globally